Endometrioid Adenocarcinoma of the Uterus: Surgico-Pathological Correlations and Role of Pelvic Lymphadenectomy

Annals of the Academy of Medicine Singapore

Volumn 32, Issue 5, 2003, Pages 670-675

  Chee, J J ^a   Ho, T H ^a   Tay, E H ^a   Low, J J H ^a   Yam, K L ^a  

^a KK WOMEN'S AND CHILDREN'S HOSPITAL   (Singapore)

Author keywords

Accurate staging; Individualised treatment; Morbidities; Nodal metastases; Pathological parameters

Indexed keywords

ADENOCARCINOMA; ADULT; AGE; AGED; ARTICLE; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER STAGING; COHORT ANALYSIS; COMPARATIVE STUDY; ENDOMETRIOID CARCINOMA; ENDOMETRIUM TUMOR; FEMALE; HUMAN; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; LYMPH NODE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; METASTASIS; METHODOLOGY; MORTALITY; NEEDLE BIOPSY; PATHOLOGY; PELVIS LYMPH NODE; PROBABILITY; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; SINGAPORE; STATISTICAL MODEL; SURVIVAL RATE; TREATMENT INDICATION; TREATMENT OUTCOME; TUMOR VOLUME; UTERUS CARCINOMA;

EID: 0242635879     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Tang X, Tanemura K, Ye W, Ohmi K, Tsunematsu R, Yamada T, et al. Clinicopathological factors predicting retroperitoneal lymph node metastases and survival in endometrial cancer. Jpn J Clin Oncol 1998; 28:673-8.
2. Basta A, Pitynski K, Oplawski M, Pesak W, Preszlakowski D, Basta P. Pathological parameters of endometrial cancer and presence of metastases in pelvic lymph nodes. Przegl Lek 2001; 58:836-8.
3. Ayhan A, Tuncer R, Tuncer Z S, Yuce K, Kucukali T. Correlation between clinical and histopathological risk factors and lymph node metastases in early endometrial cancer (A multivariate analysis of 183 cases). Int J Gynecol Cancer 1994; 4:306-9.
4. Kuroki J, Hasegawa K, Kato R, Mizukawa J, Nishio E, Nishio H, et al. Relationship between the classification of vascular invasion severity and the prognosis of uterine endometrial cancer. Int J Gynecol Cancer 2003; 13: 47-52.
5. Watanabe M, Aoki Y, Kase H, Fujita K, Tanaka K. Low risk endometrial cancer: a study of pelvic lymph node metastasis. Int J Gynecol Cancer 2003; 13:38-41.
6. Vizza E, Galati G M, Corrado G, Shiroli C. Role of pelvic lymphadenectomy in the management of stage I endometrial cancer: our experience. Eur J Gynaecol Oncol 2003; 24:126-8.
7. Candiani G B, Belloni C, Maggi R, Colombo G, Frigoli A, Carinelli S G, Evaluation of different surgical approaches in the treatment of endometrial cancer at FIGO stage I. Gynecol Oncol 1990; 37:6-8.
8. DuBeshter B, Deuel C, Gillis S, Glantz C, Angel C. Endometrial cancer: the potential role of cervical cytology in current staging. Obstet Gynecol 2003; 101:445-50.
9. Homesley H D, Kadar N, Barrett R J, Lentz S S. Selective pelvic and periaortic lymphadenectomy does not increase morbidity in surgical staging of endometrial carcinoma. Am J Obstet Gynecol 1992; 167:1225-30.
10. rd, et al. Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynaecol Oncol 1995; 56:29-33.
11. Homesley H D. Management of endometrial cancer. Am J Obstet Gynecol 1996; 174:529-34.
12. McMeekin D S, Lashbrook D, Gold M, Scribner D R, Kamelle S, Tillmans T D, et al. Nodal distribution and its significance in FIGO stage IIIc endometrial cancer. Gynecol Oncol 2001; 82:375-9.
13. Gao Y, Yu A, Chen L. Place of value of pelvic lymphadenectomy for treatment of endometrial neoplasms. Zhonghua Fu Chan Ke Za Zhi 2000; 35:264-6.
14. Franchi M, Ghezzi F, Riva C, Miglienna M, Buttarelli M, Bolis P. Postoperative complications after pelvic lymphadenectomy for the surgical staging of endometrial cancer. J Surg Oncol 2001; 78:237-7.
15. Belinson J L, Lee K R, Badger G J, Pretorius R G, Jarrell M A. Clinical stage I adenocarcinoma of the endometrium - analysis of recurrences and the potential benefit of staging lymphadenectomy. Gynaecol Oncol 1992; 44: 17-23.
16. Eltabbakh G H, Piver M S, Hempling R E, Shin K H. Excellent long-tem survival and absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: report of a prospective trial. Int J Radiat Oncol Biol Phys 1997; 38:373-80.
17. Wimberger P, Hillemanns P, Kapsner T, Hepp H, Kimmig R. Evaluation of prognostic factors following flow-cytometric DNA analysis after cytokeratin labelling. Cervical and endometrial cancer. Anal Cell Pathol 2002; 24: 147-58.
18. Larson D M, Berg R, Shaw G, Krawisz B R. Prognostic significance of DNA ploidy in endometrial cancer. Gynecol Oncol 1999; 74:356-60.
19. Hsieh C H, Chang Chien C C, Lin H, Huang E Y, Huang C C, Lan K C, et al. Can preoperative CAI25 level be a criteria for full pelvic lymphadenectomy in surgical staging of endometrial cancer? Gynecol Oncol 2002; 86:28-33.
20. Van Doorn H C, Van Der Zee A G, Peeters P H, Kroeks M V, Van Eijikeren M A. Preoperative selection of patients with low-stage endometrial cancer at high risk of pelvic lymph node metastases. Int J Gynecol Cancer 2002; 12:144-8.
21. Ohkouchi T, Sakuragi N, Watari H, Nomura E, Todo Y, Yamada H, et al. Prognostic significance of Bcl-2, p53 overexpression and lymph node metastases in surgically staged endometrial carcinoma. Am J Obstet Gynecol 2002; 187:353-9.
22. Altintas A, Cosar E, Vandar M A, Demir C, Tuncer Z. Intraoperative association of depth of myometrial invasion in endometrial carcinoma. Eur J Gynaecol Oncol 1999; 20:329-31.
23. Kayikcioglu F, Boran N, Meydanli MM, Tulunay G, Kose FM, Bulbul D. Is frozen section diagnosis a reliable guide in surgical treatment of stage I endometrial carcinoma? Acta Oncol 2002; 41:444-6.
24. Jereczek-Fossa B A, Badzio A, Jassem J. Factors determining acute normal tissue reactions during postoperative radiotherapy in endometrial cancer: analysis of 317 consecutive cases. Radiother Oncol 2003; 68:33-9.
25. Creutzberg C L, van Putten W L, Koper P C, Lybeert M L, Jobsen J J, Warlam-Rodenhuis C C, et al. The morbidity of treatment for patients with stage I endometrial cancer results from a randomised trial. Int J Radiat Oncol Biol Phys 2001; 51:1246-55.
26. Lee K M, Khoo Tan H S, Leow M K S, Sethi V K, Chua E J. Radiotherapy as local adjuvant treatment for endometrial carcinoma-a review of 45 patients. Ann Acad Med Singapore 1998; 27:636-9.